Cover Image
市場調查報告書

生命科學的商務分析 (BA)

Business Analytics in Life Sciences

出版商 Frost & Sullivan 商品編碼 368305
出版日期 內容資訊 英文 30 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
生命科學的商務分析 (BA) Business Analytics in Life Sciences
出版日期: 2016年06月24日 內容資訊: 英文 30 Pages
簡介

本報告提供生命科學的商務分析 (BA) 解決方案選擇,臨床實驗的現在的課題,課題的方法,BA解決方案的必要性,及未來臨床實驗的BA所扮演的角色等的相關分析,對企業、供應商的建議彙整,為您概述為以下內容。

第1章 摘要整理

第2章 臨床實驗的現在的課題

  • 目前課題
  • 傳統的患者採用方法的錯誤

第3章 與臨床實驗的課題對應的EHR資料主導的方法

  • 預計EHR資料的利用案例發展
  • 歐洲的EHR4CR倡議促進臨床實驗的患者資料的利用
  • 臨床實驗成功的資料主導方法的3個骨幹
  • 在以臨床研究目的,可能存取國家EHR資料庫的點,英國是先驅者

第4章 由於臨床實驗數急劇增加尋求BA解決方案的生命科學企業

  • 臨床研究數的急劇增加 - 只有複雜度與成本增加
  • 實驗贊助商因為效率提高以臨床實驗為目標

第5章 未來臨床實驗中BA所扮演的角色

  • 臨床實驗的主要的BA應用
  • BA解決方案超越KPI儀表板
  • 基礎設施零組件及資料儲存庫的演進帶來的新BI功能
  • 網際網路、資料庫企業成為了非結構化資料管理新的儲存庫
  • BI工具給予商務、終端用戶力量
  • 先進分析不是單純的資訊的互動顯示器
  • 臨床實驗的未來成本、流程最佳化焦點
  • 生命科學用BA的主要供應商比較分析

第6章 對企業、供應商的建議

  • 對企業的建議
  • 對供應商的建議
  • 免責聲明

第7章 FROST & SULLIVAN

目錄
Product Code: MC28-01-00-00-00

The Time is Ripe for a Technology Revamp in Clinical Trials

The drastic increase in the number of clinical trials performed worldwide is leading to a sharp rise in R&D expenditure incurred by life sciences companies. To overcome this challenge, companies are targeting clinical trials to achieve higher efficiencies, which will bring new drugs faster to market and reduce R&D cost burden. The solution lies in the technology revamp of future clinical trials, which is driven by implementation of effective business analytics solutions, the commoditization of hardware components, and the rise of Internet technologies offering big data analytics.

Table of Contents

1. EXECUTIVE SUMMARY

  • Key Findings
  • Executive Summary

2. CURRENT CHALLENGES IN CLINICAL TRIALS

  • Current Challenges
  • Fallacies of Traditional Patient Recruitment Methods

3. EHR DATA-DRIVEN APPROACHES TO ADDRESS CHALLENGES IN CLINICAL TRIALS

  • EHR Data Use Cases are Expected to Evolve
  • EHR4CR Initiative in Europe Promotes Patient Data Usage in Trials
  • 3 Backbones of a Successful Data-driven Approach to Clinical Trials
  • The UK is a Forerunner in Terms of Enabling Access to its National EHR Database for Clinical Research Purposes

4. LIFE SCIENCES COMPANIES TURN TO BA SOLUTIONS AS NUMBER OF CLINICAL TRIALS INCREASE DRASTICALLY

  • Number of Clinical Studies has Increased Drastically-Only to Add Complexity and Costs
  • Trial Sponsors are Targeting Clinical Trials for Efficiency Gains

5. ROLE OF BA IN FUTURE TRIALS

  • Key BA Applications for Clinical Trials
  • BA Solutions have Moved beyond KPI Dashboards
  • Evolution of Infrastructure Components and Data Repositories has Led to New BI Functionalities
  • Internet and Database Companies have Created New Repositories for Unstructured Data Management
  • BI Tools are Empowering Business and End Users
  • Advanced Analytics is not just Interactive Displays of Information
  • Future of Clinical Trials will Focus on Cost and Process Optimisation
  • Comparative Analysis of Key Vendors in BA for Life Sciences

6. RECOMMENDATIONS FOR ENTERPRISES AND VENDORS

  • Recommendations for Enterprises
  • Recommendations for Vendors
  • Legal Disclaimer

7. THE FROST & SULLIVAN STORY

  • The Frost & Sullivan Story
  • Value Proposition: Future of Your Company & Career
  • Global Perspective
  • Industry Convergence
  • 360° Research Perspective
  • Implementation Excellence
  • Our Blue Ocean Strategy
Back to Top